LifeStance Health (LFST) Cash from Investing Activities (2020 - 2026)

LifeStance Health (LFST) has 7 years of Cash from Investing Activities data on file, last reported at -$13.9 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 94.07% year-over-year to -$13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.9 million (down 81.41% YoY) and the FY2025 annual result came in at -$36.1 million, down 67.51% from the prior year.
• Cash from Investing Activities eased to -$13.9 million in Q1 2026 per LFST's latest filing, from -$10.9 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$5.1 million in Q3 2024 and bottomed at -$50.9 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$10.9 million (2025), against an average of -$16.0 million.
• The widest annual swing landed in 2022, when Cash from Investing Activities plunged 329.7%; it then surged 81.47% in 2024.
• Tracing LFST's Cash from Investing Activities over 5 years: stood at -$30.3 million in 2022, then surged by 62.33% to -$11.4 million in 2023, then jumped by 44.8% to -$6.3 million in 2024, then tumbled by 73.16% to -$10.9 million in 2025, then decreased by 27.5% to -$13.9 million in 2026.
• Per Business Quant, the three latest LFST Cash from Investing Activities figures stand at -$13.9 million (Q1 2026), -$10.9 million (Q4 2025), and -$10.3 million (Q3 2025).

Peer Comparison